Pulmonary Care and Research Collaborative Patient Registry

NCT05445817 | Unknown

• 1 other identifier: ILDC-001
• Study Type: observational
• Target: 150
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this research study is to build and maintain a registry of people with interstitial lung disease (ILD). Medical information collected for this registry may be used to advance ILD and pulmonary research and improve patient care. This is an observational registry. Participants will not receive any investigational treatments or investigational drugs as part of their participation in this registry.

Conditions

Interstitial Lung Disease

Keywords

Progressive Fibrosing Interstitial Lung Disease; Idiopathic Pulmonary Fibrosis; Interstitial Lung Disease Associated With Systemic Sclerosis; Myositis-Associated Interstitial Lung Disease; Sarcoidosis; Hypersensitivity Pneumonitis; Pulmonary Fibrosis

Outcome Measures

Primary Outcomes (1)

• Development and implementation of a database populated with de-identified longitudinal medical histories of interstitial lung disease patients.

  Up to 18 months

Secondary Outcomes (1)

• Advancing the understanding of the natural course and the treatments of interstitial lung diseases.

  Up to 18 months

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

People with a confirmed diagnosis of interstitial lung disease by a primary care physician and/or pulmonologist.

You may qualify if:

• People with a confirmed diagnosis of interstitial lung disease by a primary care physician and/or pulmonologist.

Sponsors & Collaborators

• Pulmonary Care and Research Collaborative Limited: lead
• Genentech, Inc.: collaborator

Study Sites (1)

Pulmonary Care and Research Collaborative, Ltd.

Boston, Massachusetts, 02130, United States

RECRUITING

MeSH Terms

Conditions

Lung Diseases, Interstitial; Idiopathic Pulmonary Fibrosis; Sarcoidosis; Alveolitis, Extrinsic Allergic; Pulmonary Fibrosis

Condition Hierarchy (Ancestors)

Lung Diseases; Respiratory Tract Diseases; Lymphoproliferative Disorders; Lymphatic Diseases; Hemic and Lymphatic Diseases; Hypersensitivity, Delayed; Hypersensitivity; Immune System Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Fibrosis; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Aliaa Barakat, PhD

  Pulmonary Care and Research Collaborative, Ltd.

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Aliaa Barakat, PhD

CONTACT

617-895-6636; aliaa.barakat@ildcollaborative.org

Arthur Dea, BA

CONTACT

617-895-9879; arthur.dea@ildcollaborative.org

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 18 Months
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 30, 2022
• First Posted: July 6, 2022
• Study Start: July 1, 2022
• Primary Completion: December 1, 2023
• Study Completion: March 1, 2024
• Last Updated: July 19, 2022

Record last verified: 2022-07

Locations

US (1)